BIOTRONIK Renews Commitment After Achieving Their First Milestone of Providing 1,000 Life Saving Devices One Year Earlier Than Expected
BERLIN--(Marketwire - October 1, 2012) - BIOTRONIK, a leading manufacturer of innovative medical technology, has surpassed its commitment to provide life-saving devices to more than 1,000 economically disadvantaged patients by 2013 earlier than anticipated. Through its partnership with Heartbeat International Foundation, Inc. (HBI), BIOTRONIK delivered 776 pacemakers and 405 implantable cardioverter-defibrillators (ICDs) in nearly 20 countries to date. Moreover with renewed support from BIOTRONIK, HBI is now expanding its international network to create new operational heart centers in additional countries such as China, Ethiopia and Cambodia.
"Not only has BIOTRONIK set itself the ambitious goal of saving 1,000 lives together with us -- and surpassed all expectations by providing the necessary devices almost a year early -- the company has strengthened its commitment: BIOTRONIK is now supporting HBI in its efforts to expand their activities to other regions in the world and ship devices to even more countries," explained Benedict S. Maniscalco, MD, Chairman and CEO of HBI. "The commitment made by BIOTRONIK in support of HBI's mission has set a high bar for other manufacturers of cardiac implantable devices. We want to encourage these manufacturers to take notice and join HBI in its mission."
Since 1984, HBI has been the global leader in providing devices that treat cardiac arrhythmias of patients in need -- combating the world's number one killer, cardiovascular disease. Estimates indicate that 82% of cardiovascular disease originates in low- and middle-income countries -- and up to 3 million people die each year because they are unable to afford a pacemaker or ICD.
BIOTRONIK's partnership with HBI is dedicated to reducing those preventable fatalities by providing top-of-the-line cardiovascular implantable devices and subsequent treatment to economically disadvantaged patients free of charge -- regardless of age, gender, religion, culture or political persuasion.
"As a company that is known for its dedication to patients' health, we see it as our duty to advance initiatives that give economically disadvantaged patients access to life-saving, high quality care," said Christoph Böhmer, President International, BIOTRONIK. "BIOTRONIK's donation of cardiac devices to HBI's program is an important part of this commitment. Working with Heartbeat International Foundation, we are continuously looking for new ways to save even more patients. We are proud as a leading global manufacturer of cardiovascular therapies to support HBI and advance our alliance together."
Worldwide New HBI Alliances
By way of the One Heart Global Cardiovascular Alliance, HBI is in partnering discussions with many other nonprofit organizations located in countries where HBI has not yet established operational heart centers. Among these nonprofit organizations are groups such as the Love-Heart Project in China, led by Professor Dayi Hu, one of China's leading cardiologists, and the Pan-African Society of Cardiology and the African Heart Network -- both of which cover multiple countries and have hundreds of physician members.
"HBI is grateful for BIOTRONIK's continued support and is privileged to count them as a strategic partner in the expansion of our primary mission of providing comprehensive cardiovascular services through the Global Cardiovascular Alliance," commented Maniscalco.
For more information about HBI, visit: www.heartbeatsaveslives.org
For more information about BIOTRONIK, visit: www.biotronik.com
About BIOTRONIK SE & Co. KG
As one of the world's leading manufacturers of cardiovascular medical devices, with several million devices implanted, BIOTRONIK is represented in over 100 countries by its global workforce of more than 5,600 employees. Known for having its finger on the pulse of the medical community, BIOTRONIK assesses the challenges physicians face and provides the best solutions for all phases of patient care, ranging from diagnosis to treatment to patient management. Quality, innovation and reliability define BIOTRONIK and its growing success -- and deliver confidence and peace of mind to physicians and their patients worldwide.
Contact
Sandy Hathaway
Senior Director, Global Communications
BIOTRONIK SE & Co KG
Woermannkehre 1
12359 Berlin
+49 (0) 30 68905 1602
sandy.hathaway@biotronik.com
© 2012 Marketwire, Incorporated. All rights reserved.
No comments:
Post a Comment